Related references
Note: Only part of the references are listed.Clinical application of Albumin-Bilirubin (ALBI) score: The current status
Min Deng et al.
SURGEON-JOURNAL OF THE ROYAL COLLEGES OF SURGEONS OF EDINBURGH AND IRELAND (2020)
Adverse event profiles of ifosfamide-induced encephalopathy analyzed using the Food and Drug Administration Adverse Event Reporting System and the Japanese Adverse Drug Event Report databases
Kazuyo Shimada et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2019)
Possible role of CYP2B6 genetic polymorphisms in ifosfamide-induced encephalopathy: report of three cases
Thomas Duflot et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2018)
Review of Advances in Uroprotective Agents for Cyclophosphamide- and Ifosfamide-induced Hemorrhagic Cystitis
Ethan L. Matz et al.
UROLOGY (2017)
Risk factors of ifosfamide-related encephalopathy in adult patients with cancer: A retrospective analysis
Yin Lo et al.
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2016)
Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach-The ALBI Grade
Philip J. Johnson et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
An assessment of risk factors associated with ifosfamide-induced encephalopathy in a large academic cancer center
Audrea H. Szabatura et al.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE (2015)
Ifosfamide encephalopathy associated with chemotherapy for musculoskeletal sarcomas: incidence, severity, and risk factors
Takahiro Tajino et al.
JOURNAL OF ORTHOPAEDIC SCIENCE (2010)
Encephalopathy after High-Dose Ifosfamide A Retrospective Cohort Study and Review of the Literature
Karen I. Sweiss et al.
DRUG SAFETY (2008)
Ifosfamide neuropsychiatric toxicity in patients with cancer
Yesne Alici-Evcimen et al.
PSYCHO-ONCOLOGY (2007)
Evaluating risk factors for the development of ifosfamide encephalopathy
KA David et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2005)
Incidence and severity of ifosfamide-induced encephalopathy
C Rieger et al.
ANTI-CANCER DRUGS (2004)
Clinical pharmacokinetics and pharmacodynamics of ifosfamide and its metabolites
T Kerbusch et al.
CLINICAL PHARMACOKINETICS (2001)
Share Paper
